July 06, 2017

Manchin Applauds Decision by Endo International to Remove Opioid Pain Medication from Market

Washington, D.C. – Today U.S. Senator Joe Manchin (D-WV) applauded Endo International’s decision to voluntarily pull its opioid pain medication, Opana ER, from the market. Last month, Senator Manchin and the Food and Drug Administration (FDA) asked Endo International to cease selling the medication after determining that the drug’s risks outweighed its medical benefits and that it was contributing to the opioid epidemic in West Virginia and across the country.

“I’m glad to see that Endo International has made the responsible choice to remove Opana from the market,” Senator Manchin said. “Removing Opana is an important step in combating the country’s opioid epidemic that takes the lives of hundreds of West Virginians each year. I’ve seen firsthand the horrific impact the opioid epidemic is having on West Virginia families and communities. While this is an important step, there is more work to be done to ensure every West Virginia family has access to quality treatment facilities and end this epidemic once and for all.”

To review a timeline of Senator Manchin’s efforts in the Senate to combat prescription drug abuse, please click here.